The target price lets investors set an expected value for an asset, helping define buy or sell points.
Choose whether you would like to receive an alert for your Target Price.
The target price lets investors set an expected value for an asset, helping define buy or sell points.
This asset and the price you set will be removed from your target price list and this cannot be undone.
Congratulations! Your Target Price strategy has reached 5 alerts. Now take the next step: upgrade and unlock unlimited alerts to capture every market opportunity.
Unlock unlimited alerts
This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]
Current Dividend Yield
%
5-year average Dividend Yield
0.00%
Current Payout
—
5-year average Payout
—
Average Investor10 user rating
4.0
(0 people)
Founded: 2020
Time since IPO - 6 years
Employees
Therapeutics Acquisition Corp. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $130.64 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Therapeutics Acquisition Corp. reported $- in revenue, generating net income of $-1.81 million.
Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.
The company trades under the ticker RACA.
Market cap
$-
$-
Net worth
$130.64 million
$130,641,040.00
Assets
$136.50 million
$136,498,090.00
Total Shares Outstanding
17.43 million
17,433,000
Average Daily Trading Volume
$218.46 Thousand
$218,464.14
Shares
14.36
0.00%
12.11%
1.64
14.35
0.00%
12.12%
1.64
13.87
1.81%
17.92%
2.45
4.48
1.77%
14.31%
0.62
12.04
0.00%
21.85%
2.23
10.52
4.42%
14.40%
1.50
12.22
2.01%
17.71%
2.15
6.49
2.46%
26.89%
1.55
14.36
0.00%
12.11%
1.64
14.35
0.00%
12.12%
1.64
13.87
1.81%
17.92%
2.45
4.48
1.77%
14.31%
0.62
12.04
0.00%
21.85%
2.23
10.52
4.42%
14.40%
1.50
12.22
2.01%
17.71%
2.15
6.49
2.46%
26.89%
1.55
The current price of Therapeutics Acquisition (RACA) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.
Therapeutics Acquisition (RACA) did not pay dividends over the past year.
Therapeutics Acquisition (RACA) is currently trading at $0.00 with a P/E ratio of 0.00. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of -%. The total shareholder return over the same period was 0.00%.
Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.
You can buy Therapeutics Acquisition (RACA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol RACA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.
Over the past month, Therapeutics Acquisition (RACA) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.
In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of -%.
If you were to purchase 100 shares of Therapeutics Acquisition (RACA) today at the current price of $0.00 your total investment would be $0.00.
Based on historical performance, the investment would have grown to approximately:
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
